Trade Groups Suggest Office Upgrade For FDA Supplement Division
This article was originally published in The Tan Sheet
Executive Summary
An upgrade “would enhance the effectiveness of dietary supplement regulation by allowing this new Office to better compete for resources and attention within the Agency,” say CPHPA, CRN, NPA and UNPA.
You may also be interested in...
Senators Push Park Doctrine Prosecution For Spiked Supplement ‘Criminal Endeavors’
Key industry allies say they are “deeply concerned” about “blatant criminal activity” in products marketed as supplements but containing anabolic steroids or other drugs. “Bring a few of these actions and you scare people into the idea that … you could actually go to jail,” says attorney Frederick Stearns.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.